Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

ClinicalTrials.gov ID: NCT00501059

Public ClinicalTrials.gov record NCT00501059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group Study to Assess the Efficacy (Reduction of Cardiovascular Disease Events) and Safety of 100 mg Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The use of acetylsalicylic acid in the primary prevention of cardiovascular events has been extensively studied but to a lesser extent in patients with moderate levels of cardiovascular risk. The current study is designed to prove the efficacy and tolerability of 100 mg enteric-coated Aspirin versus placebo in the prevention of cardiovascular disease (CVD) events, which include fatal and nonfatal myocardial infarction, fatal and nonfatal stroke and CV death, in a population with no history of known CVD who are at moderate risk of major CHD events (approximately 10-20% 10 year CHD risk). This corresponds to a patient population mean 10-year CVD risk of approximately 30%. Subjects are treated in a standard care setting and may receive treatment for the underlying risk factors as defined by the treating physician. Outcome events will be adjudicated by an Endpoint Adjudication Committee and the study will be monitored by an independent Data Safety Monitoring Board.

Study identification

NCT ID
NCT00501059
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
12,546 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 4, 2007
Primary completion
Nov 14, 2016
Completion
Nov 14, 2016
Last update posted
Oct 25, 2018

2007 – 2016

United States locations

U.S. sites
73
U.S. states
22
U.S. cities
70
Facility City State ZIP Site status
Not listed Birmingham Alabama 39294
Not listed Graysville Alabama 35073
Not listed Pell City Alabama 35125
Not listed Phoenix Arizona 85051
Not listed Scottsdale Arizona 85260
Not listed Tucson Arizona 85712
Not listed Hot Springs Arkansas 71913-4457
Not listed Fremont California 94536-3702
Not listed Huntington Park California 90255
Not listed Los Angeles California 90025
Not listed Rancho Cucamonga California 91730
Not listed Rolling Hills Estates California 90274
Helping Hands Clinical Trials Santa Ana California 92704
Not listed Newark Delaware 19702
Medical Research Trust Boynton Beach Florida 33426
Not listed Gainesville Florida 32601
Not listed Hialeah Florida 33016
Medical Research Centers of South Florida, Inc. Hollywood Florida 33021
Office of Dr.Larry Levinson, DO Hollywood Florida 33021
Not listed Kissimmee Florida 34741
Not listed Largo Florida 33770
Not listed Marianna Florida 32446-2120
Not listed Panama City Florida 32401
Tallahassee Memorial Family Quincy Florida 32351
Not listed Tampa Florida 33614
Not listed Atlanta Georgia 30318
Not listed Chicago Illinois 60628
Not listed Chicago Illinois 60631-1958
Not listed Lockport Illinois 60491
Not listed Vernon Hills Illinois 60061
Not listed Evansville Indiana 47713
Not listed Fort Wayne Indiana 46804
Not listed Lebanon Kentucky 40033
Not listed Prince Frederick Maryland 20678
Not listed Bridgman Michigan 49106
Not listed Cadillac Michigan 49601
Not listed Interlochen Michigan 49643-9264
Not listed Troy Michigan 48085
Not listed Port Gibson Mississippi 39150
Not listed Florissant Missouri 63031
Not listed Broken Bow Nebraska 68822
Not listed Omaha Nebraska 68114
Not listed Omaha Nebraska 68116-2004
Not listed Belvidere New Jersey 07823
Not listed Cherry Hill New Jersey 08084
Not listed Clifton New Jersey 07013
Not listed Hainesport New Jersey 08036
Not listed Jersey City New Jersey 07306
Not listed Lawrenceville New Jersey 08648
Not listed Linden New Jersey 07036
PharmaTrials, Inc. Perth Amboy New Jersey 08861
Not listed Stratford New Jersey 08084
Not listed Burlington North Carolina 27215
Not listed Columbus North Carolina 28722
Not listed Greensboro North Carolina 27401
Not listed Raleigh North Carolina 27609
Not listed Carlisle Ohio 45005-3320
Not listed Marion Ohio 43302
Not listed Montgomery Ohio 45242
Not listed Perrysburg Ohio 43551
Not listed Doylestown Pennsylvania 18901
Not listed Duncansville Pennsylvania 16635
Not listed Sellersville Pennsylvania 18960
Not listed Taylors South Carolina 29687
Not listed Daingerfield Texas 75638
Not listed McKinney Texas 75069
Not listed Rockwall Texas 75032
Not listed San Antonio Texas 78205-1116
Not listed San Marcos Texas 78666
Not listed Stephenville Texas 76401
Not listed Sugar Land Texas 77478
Not listed Honaker Virginia 24260
Merit Medical Group, Inc. Richlands Virginia 24641-2067

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 393 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00501059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2018 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00501059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →